Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta

Preeclampsia (PE) is one of the commonest causes for maternal and fetal morbidity and mortality. Imbalances of angiogenic factors, oxidative stress, and inflammatory response have a role in the pathogenesis of PE. Data regarding the circulating apelin level and its role in PE remains controversial....

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Reham Z. Hamza, Abdel Aziz A. Diab, Mansour H. Zahra, Ali K. Asalah, Suzan M. M. Moursi, Najah M. Al-Baqami, Fawziah A. Al-Salmi, Mai S. Attia
Formato:	article
Lenguaje:	EN
Publicado:	Hindawi Limited 2021
Materias:	Diseases of the endocrine glands. Clinical endocrinology RC648-665
Acceso en línea:	https://doaj.org/article/7c7cadff1ce244c0bcc3c7b79cfef524
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:7c7cadff1ce244c0bcc3c7b79cfef524
record_format	dspace
spelling	oai:doaj.org-article:7c7cadff1ce244c0bcc3c7b79cfef5242021-11-29T00:56:17ZCorrelation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta1687-834510.1155/2021/5017362https://doaj.org/article/7c7cadff1ce244c0bcc3c7b79cfef5242021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/5017362https://doaj.org/toc/1687-8345Preeclampsia (PE) is one of the commonest causes for maternal and fetal morbidity and mortality. Imbalances of angiogenic factors, oxidative stress, and inflammatory response have a role in the pathogenesis of PE. Data regarding the circulating apelin level and its role in PE remains controversial. This study was formulated to assess the serum apelin level in PE, investigate its correlation with some inflammatory, oxidative stress, and angiogenic proteins in a nitric oxide synthase inhibitor; the N (gamma)-nitro-L-arginine methyl ester (L-NAME)-induced rat model of PE and determine whether apelin administration could protect against development of PE. 40 healthy adult female albino rats and 10 adult male albino rats were used in this study. The pregnant female rats were randomly divided into three groups: group 1 (normal pregnant group), group 2 (PE-induced group), injected subcutaneously with 75 mg L-NAME/kg bodyweight/day starting from day 9 to 20 of gestation, and group 3 (PE-induced group supplemented with apelin (PE + apelin)); PE induced as before and simultaneously subcutaneously injected with apelin-13 (6 × 10−8 mol/kg bodyweight/twice daily) beginning from day 6 to 20 of gestation. In all groups, blood pressure and urine protein were determined at gestation days (GD) 0, 10, and 18. Moreover, serum apelin, placental growth factor (PLGF), vascular endothelial growth factor (VEGF), soluble fms-like tyrosine kinase-1 (sFlt-1), soluble endoglin (sEng), interferon-gamma (IFN-γ), and interleukin-10 (IL-10) levels and serum superoxide dismutase enzyme (SOD) and catalase (CAT) activities of all groups were estimated at the end of experiment. Placental histopathological examination was also performed. PE-induced rats showed significantly decreased serum apelin levels. Moreover, they showed significantly increased blood pressures, urine proteins, sFlt-1, sEng, and IFN-γ (mean arterial blood pressure, urine proteins, sFlt-1, sEng, and IFN-γ showed significant negative correlations with serum apelin level), but it showed significantly decreased VEGF, PLGF, IL-10, SOD, and CAT (VEGF, PLGF, IL-10, and SOD showed significant positive correlations with serum apelin level). In contrast, exogenous apelin administration significantly ameliorated these parameters together with improvement in the placental histoarchitecture in the apelin-supplemented PE group. This study demonstrated the protective effects of apelin administration on the pathogenesis of PE.Reham Z. HamzaAbdel Aziz A. DiabMansour H. ZahraAli K. AsalahSuzan M. M. MoursiNajah M. Al-BaqamiFawziah A. Al-SalmiMai S. AttiaHindawi LimitedarticleDiseases of the endocrine glands. Clinical endocrinologyRC648-665ENInternational Journal of Endocrinology, Vol 2021 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the endocrine glands. Clinical endocrinology RC648-665
spellingShingle	Diseases of the endocrine glands. Clinical endocrinology RC648-665 Reham Z. Hamza Abdel Aziz A. Diab Mansour H. Zahra Ali K. Asalah Suzan M. M. Moursi Najah M. Al-Baqami Fawziah A. Al-Salmi Mai S. Attia Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta
description	Preeclampsia (PE) is one of the commonest causes for maternal and fetal morbidity and mortality. Imbalances of angiogenic factors, oxidative stress, and inflammatory response have a role in the pathogenesis of PE. Data regarding the circulating apelin level and its role in PE remains controversial. This study was formulated to assess the serum apelin level in PE, investigate its correlation with some inflammatory, oxidative stress, and angiogenic proteins in a nitric oxide synthase inhibitor; the N (gamma)-nitro-L-arginine methyl ester (L-NAME)-induced rat model of PE and determine whether apelin administration could protect against development of PE. 40 healthy adult female albino rats and 10 adult male albino rats were used in this study. The pregnant female rats were randomly divided into three groups: group 1 (normal pregnant group), group 2 (PE-induced group), injected subcutaneously with 75 mg L-NAME/kg bodyweight/day starting from day 9 to 20 of gestation, and group 3 (PE-induced group supplemented with apelin (PE + apelin)); PE induced as before and simultaneously subcutaneously injected with apelin-13 (6 × 10−8 mol/kg bodyweight/twice daily) beginning from day 6 to 20 of gestation. In all groups, blood pressure and urine protein were determined at gestation days (GD) 0, 10, and 18. Moreover, serum apelin, placental growth factor (PLGF), vascular endothelial growth factor (VEGF), soluble fms-like tyrosine kinase-1 (sFlt-1), soluble endoglin (sEng), interferon-gamma (IFN-γ), and interleukin-10 (IL-10) levels and serum superoxide dismutase enzyme (SOD) and catalase (CAT) activities of all groups were estimated at the end of experiment. Placental histopathological examination was also performed. PE-induced rats showed significantly decreased serum apelin levels. Moreover, they showed significantly increased blood pressures, urine proteins, sFlt-1, sEng, and IFN-γ (mean arterial blood pressure, urine proteins, sFlt-1, sEng, and IFN-γ showed significant negative correlations with serum apelin level), but it showed significantly decreased VEGF, PLGF, IL-10, SOD, and CAT (VEGF, PLGF, IL-10, and SOD showed significant positive correlations with serum apelin level). In contrast, exogenous apelin administration significantly ameliorated these parameters together with improvement in the placental histoarchitecture in the apelin-supplemented PE group. This study demonstrated the protective effects of apelin administration on the pathogenesis of PE.
format	article
author	Reham Z. Hamza Abdel Aziz A. Diab Mansour H. Zahra Ali K. Asalah Suzan M. M. Moursi Najah M. Al-Baqami Fawziah A. Al-Salmi Mai S. Attia
author_facet	Reham Z. Hamza Abdel Aziz A. Diab Mansour H. Zahra Ali K. Asalah Suzan M. M. Moursi Najah M. Al-Baqami Fawziah A. Al-Salmi Mai S. Attia
author_sort	Reham Z. Hamza
title	Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta
title_short	Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta
title_full	Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta
title_fullStr	Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta
title_full_unstemmed	Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta
title_sort	correlation between apelin and some angiogenic factors in the pathogenesis of preeclampsia: apelin-13 as novel drug for treating preeclampsia and its physiological effects on placenta
publisher	Hindawi Limited
publishDate	2021
url	https://doaj.org/article/7c7cadff1ce244c0bcc3c7b79cfef524
work_keys_str_mv	AT rehamzhamza correlationbetweenapelinandsomeangiogenicfactorsinthepathogenesisofpreeclampsiaapelin13asnoveldrugfortreatingpreeclampsiaanditsphysiologicaleffectsonplacenta AT abdelazizadiab correlationbetweenapelinandsomeangiogenicfactorsinthepathogenesisofpreeclampsiaapelin13asnoveldrugfortreatingpreeclampsiaanditsphysiologicaleffectsonplacenta AT mansourhzahra correlationbetweenapelinandsomeangiogenicfactorsinthepathogenesisofpreeclampsiaapelin13asnoveldrugfortreatingpreeclampsiaanditsphysiologicaleffectsonplacenta AT alikasalah correlationbetweenapelinandsomeangiogenicfactorsinthepathogenesisofpreeclampsiaapelin13asnoveldrugfortreatingpreeclampsiaanditsphysiologicaleffectsonplacenta AT suzanmmmoursi correlationbetweenapelinandsomeangiogenicfactorsinthepathogenesisofpreeclampsiaapelin13asnoveldrugfortreatingpreeclampsiaanditsphysiologicaleffectsonplacenta AT najahmalbaqami correlationbetweenapelinandsomeangiogenicfactorsinthepathogenesisofpreeclampsiaapelin13asnoveldrugfortreatingpreeclampsiaanditsphysiologicaleffectsonplacenta AT fawziahaalsalmi correlationbetweenapelinandsomeangiogenicfactorsinthepathogenesisofpreeclampsiaapelin13asnoveldrugfortreatingpreeclampsiaanditsphysiologicaleffectsonplacenta AT maisattia correlationbetweenapelinandsomeangiogenicfactorsinthepathogenesisofpreeclampsiaapelin13asnoveldrugfortreatingpreeclampsiaanditsphysiologicaleffectsonplacenta
_version_	1718407716953653248

Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta

Ejemplares similares